PHILADELPHIA — Susan Mandel, MD, MPH, professor of Medicine and Radiology, and Associate Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Pennsylvania’s Perelman School of Medicine, has been elected vice president, Physician-in-Practice, of The Endocrine Society. In addition, Mitchell Lazar, MD, PhD, Sylvan Eisman Professor of Medicine, Chief of the Division of Endocrinology, Diabetes and Metabolism, and Director of the Institute for Diabetes, Obesity and Metabolism, was elected to serve as a council member, at-large. They will collaborate with other newly elected Officers and Council members to lead the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology.
The new Officers and Council members will begin serving their terms following ENDO 2013, the 95th Annual Meeting & Expo of The Endocrine Society. The meeting will take place in San Francisco, June 15-18, 2013.
"This position provides a great platform to advocate for the optimal care of patients with endocrine disorders," said Dr. Mandel. "I'm eager to take on this challenge, particularly in light of forthcoming changes to reimbursement structure with enactment of the Affordable Care Act."
Dr. Mandel will serve a three-year term as Vice President, Physician-in-Practice (2013-2016). She is the Director of Clinical Endocrinology and Diabetes for the University of Pennsylvania Health System and the program director of the Fellowship in Endocrinology, Diabetes and Metabolism. Active in the Society for more than two decades, she has represented practicing physicians on the Society’s Council and served as the Council’s liaison to the Advocacy and Public Outreach Core Committee. Mandel founded and led the Society’s Hands-On Thyroid Ultrasound Workshops. She chaired the Nominating Committee and is active in the Self-Assessment Committee, the ENDO Task Force and the Web Member Task Force. She has served on The Journal of Clinical Endocrinology and Metabolism’s editorial board. Mandel will travel to South Africa in April to participate in The Endocrine Society’s Ambassador Exchange program. She has received numerous honors and awards, including the Society’s Distinguished Educator Award. Mandel received her MD from Columbia University.
Dr. Lazar will serve a three-year term as an at-large member of Council. Since joining the Society in 1989, Lazar has served on the Society’s Awards Committee and represented the Society on the Federation of American Societies for Experimental Biology (FASEB) Federal Funding Subcommittee. He has provided editorial leadership to numerous journals, including Endocrine Reviews, Endocrinology and Molecular Endocrinology. Among his many awards and honors, Lazar has most recently been recognized with the Society’s Gerald D. Aurbach Lecture Award, where he’ll present at the June ENDO meeting. He received his MD and PhD from Stanford University.
Founded in 1916, The Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society’s membership consists of over 16,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.